We are live on ! Find out more
O

Ossiam Portfolio holdings

AUM $5.69B
1-Year Est. Return 30.95%
This Fund
S&P 500
This Quarter Est. Return
-5.8%
1 Year Est. Return
+30.95%
3 Year Est. Return
+104.81%
5 Year Est. Return
+127.55%
10 Year Est. Return
AUM
$3.82B
AUM Growth
+$5.43M
Cap. Flow
+$252M
Cap. Flow %
6.6%
Top 10 Hldgs %
37.58%
Holding
486
New
53
Increased
195
Reduced
170
Closed
54

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$149M
2
AAPL icon
Apple
AAPL
+$115M
3
TSLA icon
Tesla
TSLA
+$73.9M
4
PYPL icon
PayPal
PYPL
+$70.7M
5
BF.B icon
Brown-Forman Class B
BF.B
+$27.9M

Top Sells

Rank Stock Value
1
TMUS icon
T-Mobile US
TMUS
+$70.2M
2
BLK icon
Blackrock
BLK
+$47.3M
3
TFC icon
Truist Financial
TFC
+$32.6M
4
VZ icon
Verizon
VZ
+$30.5M
5
EA icon
Electronic Arts
EA
+$29.5M

Sector Composition

Rank Sector Weight
1 Technology 31.02%
2 Financials 19.21%
3 Communication Services 12.34%
4 Healthcare 11.53%
5 Consumer Discretionary 11.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GS icon
26
Goldman Sachs
GS
$313B
$36M 0.94%
109,081
-726
-0.7% -$256K
UNH icon
27
UnitedHealth
UNH
$382B
$35.1M 0.92%
68,784
-6,184
-8% -$2.98M
WFC icon
28
Wells Fargo
WFC
$261B
$33.9M 0.89%
700,000
+175,000
+33% +$9.37M
CHD icon
29
Church & Dwight Co
CHD
$23.1B
$32.9M 0.86%
331,064
+256,341
+343% +$25.5M
BF.B icon
30
Brown-Forman Class B
BF.B
$12B
$28.7M 0.75%
428,839
+419,804
+4,646% +$27.9M
MS icon
31
Morgan Stanley
MS
$337B
$27.8M 0.73%
317,620
+7,760
+3% +$749K
C icon
32
Citigroup
C
$222B
$27.8M 0.73%
519,763
+169,643
+48% +$10.5M
FISV
33
Fiserv Inc
FISV
$27.2B
$27.5M 0.72%
270,790
+342
+0.1% +$34.6K
CL icon
34
Colgate-Palmolive
CL
$72.6B
$27M 0.71%
356,586
+345,577
+3,139% +$27.4M
PNC icon
35
PNC Financial Services
PNC
$100B
$26.9M 0.7%
145,613
+67,349
+86% +$13.6M
EL icon
36
Estee Lauder
EL
$29B
$25.7M 0.67%
94,517
+89,335
+1,724% +$26.9M
VRTX icon
37
Vertex Pharmaceuticals
VRTX
$121B
$24.6M 0.64%
94,074
+4,020
+4% +$954K
TMO icon
38
Thermo Fisher Scientific
TMO
$211B
$23.7M 0.62%
40,134
+11,319
+39% +$6.5M
NVDA icon
39
NVIDIA
NVDA
$5.01T
$23.2M 0.61%
849,020
+560,460
+194% +$14.1M
VRSN icon
40
VeriSign
VRSN
$25.3B
$22.4M 0.58%
100,494
+3,330
+3% +$726K
ABT icon
41
Abbott
ABT
$180B
$22.3M 0.58%
188,457
+162,334
+621% +$20.1M
SNPS icon
42
Synopsys
SNPS
$71.5B
$21.6M 0.57%
64,810
+3,500
+6% +$1.09M
FFIV icon
43
F5
FFIV
$22.1B
$21.5M 0.56%
102,721
-984
-0.9% -$207K
SYY icon
44
Sysco
SYY
$39.7B
$20.7M 0.54%
253,642
+236,762
+1,403% +$19.1M
DB icon
45
Deutsche Bank
DB
$66.3B
$19.3M 0.51%
1,507,667
+1,082,990
+255% +$14.4M
V icon
46
Visa
V
$677B
$18.6M 0.49%
83,804
+64,697
+339% +$14M
AMGN icon
47
Amgen
AMGN
$203B
$18.6M 0.49%
76,844
+64,825
+539% +$14.9M
MRSH
48
Marsh
MRSH
$86.3B
$18.3M 0.48%
107,659
-60,439
-36% -$9.53M
SPGI icon
49
S&P Global
SPGI
$126B
$17.4M 0.46%
42,401
-9,674
-19% -$3.94M
ON icon
50
ON Semiconductor
ON
$33.8B
$17.2M 0.45%
274,859
-3,607
-1% -$220K

Similar funds

Ossiam's Q1 2022 Portfolio in Review

As of Q1 2022, Ossiam held 486 positions worth $3.82B, up 0.14% from $3.82B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Ossiam deployed $252M of net new capital in Q1 2022, opening 53 new positions and adding to 195 existing holdings. Its largest new stake was CVS Health: 168,589 shares worth $17.1M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 26% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was T-Mobile US, an estimated $70.2M trimmed.

  • Ossiam's largest Q1 2022 buy was CVS Health: 168,589 shares worth $17.1M.
  • Ossiam added most to Microsoft in Q1 2022, an estimated $149M increase.
  • Ossiam's biggest Q1 2022 reduction was T-Mobile US, cutting an estimated $70.2M.
  • Ossiam fully exited Blackrock in Q1 2022, selling an estimated $47.3M.
  • Ossiam's ten largest holdings make up 38% of its $3.82B portfolio in Q1 2022.
  • Ossiam opened 53 new positions and closed 54 in Q1 2022.
  • Ossiam's portfolio value rose 0.14% quarter-over-quarter to $3.82B.

Based on Ossiam's 13F filing for Q1 2022, filed 13 May 2022.